Search

Search Constraints

You searched for: Author/Creator Zhao, H

Search Results

31. Model-informed drug development approach supporting approval of the 4-week (Q4W) dosing schedule for nivolumab (Opdivo) across multiple indications: a regulatory perspective. (2nd February 2019)

39. Prognostic significance of the interval between the initiation of antiretroviral therapy and the initiation of anti‐tuberculosis treatment in HIV/tuberculosis‐coinfected patients: results from the TREAT Asia HIV Observational Database. Issue 2 (28th August 2013)